SEC Form 4 · accession 0000891293-16-000154
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phillip M Nudelman Ph.D.
Director
Period of report
Apr 29, 2016
Accepted (ET)
Apr 29, 2016 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 29, 2016 | M | 79,618 | — | A | 334,311 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | Apr 29, 2016 | M | 79,618 | D | — | — | Common Stock | 79,618 | 0 | D |
| Restricted Stock UnitF3,F4 | — | Apr 29, 2016 | A | 396,983 | A | — | — | Common Stock | 396,983 | 396,983 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- F2This restricted stock unit was granted on September 23, 2015 and vested on April 29, 2016.
- F3Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock.
- F4This restricted stock unit was granted on April 29, 2016 and scheduled to vest twelve months after grant date or, if earlier, the first annual meeting of CTIC's shareholders in 2017 at which one or more members of the CTIC Board of Directors are to be elected.